Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

352 ARTÍCULOS , VIENDO DEL 46 AL 60

Exploring precision medicine by utilizing individual genetic information for the management of Alzheimer's disease

Kanda A, Rani A, Mazumder A.

Pharmacogenomics. 2025 Jul-Aug;26(10-12):455-474. doi: 10.1080/14622416.2025.2560296. Epub 2025 Sep 15.

Understanding Cerebral Blood Flow Dynamics for Alzheimer's Disease Prevention Through Acute Exercise (flADex): Protocol for a Randomized Crossover Trial

Martín-Fuentes I, Fernandez-Gamez B, Vidal-Almela S, Caro-Rus A, Solis-Urra P, Sánchez-Aranda L, Fernández-Ortega J, Sanchez-Martinez J, Coca-Pulido A, Olvera-Rojas M, Barranco-Moreno EJ, Marin-Alvarez JD, Bakker EA, Toval A, Bellón D, Sclafani A, Karikari TK, Erickson KI, Gómez-Río M, Ortega FB, Esteban-Cornejo I.

Brain Behav. 2025 Nov;15(11):e70636. doi: 10.1002/brb3.70636.

Molecular Biomarkers for Early Detection of Alzheimer's Disease and the Complementary Role of Engineered Nanomaterials: A Systematic Review

Zia Ul Haq M, Zhao X, Obeng Apori S, Singh B, Tian F.

Int J Mol Sci. 2025 Sep 23;26(19):9282. doi: 10.3390/ijms26199282.

Electrochemical Biosensors Combined with Nanomaterial Signal Amplification for the Detection of Alzheimer's Disease Biomarkers in Blood

Peng L, Xie X, Chen X, Chen C.

ACS Sens. 2025 Sep 26;10(9):6380-6405. doi: 10.1021/acssensors.5c02453. Epub 2025 Sep 8.

Influence of age and sex on presymptomatic phases of neurodegenerative diseases: Focus on multiple sclerosis and Alzheimer's disease

Zeydan B, Kantarci K.

Rev Neurol (Paris). 2025 Nov;181(9):829-838. doi: 10.1016/j.neurol.2025.06.015. Epub 2025 Aug 6.

Examining the role of antioxidant supplementation in mitigating oxidative stress markers in Alzheimer's disease: a comprehensive review

Jawad M, Uthirapathy S, Altalbawy FMA, Oghenemaro EF, Rizaev J, Lal M, Eldesoqui M, Sharma N, Pramanik A, Al-Hamairy AK.

Inflammopharmacology. 2025 Feb;33(2):573-592. doi: 10.1007/s10787-024-01622-9. Epub 2024 Dec 19.

Microfluidics in neural extracellular vesicles characterization for early Alzheimer's disease diagnosis

Zare H, Kasdorf MM, Bakhshian Nik A.

Mol Cell Neurosci. 2025 Mar;132:103982. doi: 10.1016/j.mcn.2024.103982. Epub 2024 Dec 3.

Comparison of CSF neurofilament light chain and total tau as neurodegeneration markers: Associations with synaptic markers and cognitive outcomes

Richter G, Kirsebom BE, Jarholm JA, Pålhaugen L, Gísladóttir B, Aarsland D, Grøntvedt GR, Skogseth RE, Waterloo K, Fladby T, Nordengen K.

Neurobiol Aging. 2025 Nov;155:13-23. doi: 10.1016/j.neurobiolaging.2025.07.005. Epub 2025 Jul 10.

Critical nodes in precision diagnosis and treatment of Alzheimer's disease: exploration of multidimensional biomarkers and prospects for targeted intervention

Zuo Y, Ding X, Sun Y, Wang L, Song Y, Zhao Z, Liu C.

J Neurol Sci. 2025 Dec 15;479:123734. doi: 10.1016/j.jns.2025.123734. Epub 2025 Oct 28.

Cerebrospinal Fluid Biomarkers and Cognition in Alzheimer Disease and Frontotemporal Dementia in a Memory Clinic Setting

Cayir S, Sadabad FE, Mecca AP, Matuskey D, Fesharaki-Zadeh A.

Alzheimer Dis Assoc Disord. 2025 Jan-Mar 01;39(1):22-27. doi: 10.1097/WAD.0000000000000656. Epub 2025 Jan 13.

Association between Serum Levels of Interleukin-6 and Stroke, Cardiovascular Events, and Alzheimer's Disease Dementia

Kitagawa K, Toi S, Yoshizawa H, Sato Y, Todo K.

J Atheroscler Thromb. 2025 Nov 1;32(11):1390-1399. doi: 10.5551/jat.65763. Epub 2025 Jun 6.

The neuroinflammatory role of microRNAs in Alzheimer's disease: pathological insights to therapeutic potential

Liu W, Rao X, Sun W, Chen X, Yu L, Zhang J, Chen J, Zheng X.

Mol Cell Biochem. 2025 May;480(5):2689-2706. doi: 10.1007/s11010-024-05164-0. Epub 2024 Nov 20.

Integrating artificial intelligence with small molecule therapeutics and precision medicine for neurochemical understanding of Alzheimer's diseases

Alshehri ZS.

Neuroscience. 2025 Nov 1;586:44-57. doi: 10.1016/j.neuroscience.2025.08.055. Epub 2025 Sep 18.

Fast Declining Prediction in Alzheimer's Disease from Early Clinical Assessment

Alvarez-Sanchez L, Pereto M, Garcia-Valles L, Balaguer A, Pena-Bautista C, Ferre-Gonzalez L, Baquero M, Pericas CC.

Curr Neuropharmacol. 2025;23(5):602-611. doi: 10.2174/011570159X332930240925095423.

Preclinical Cognitive Markers of Alzheimer Disease and Early Diagnosis Using Virtual Reality and Artificial Intelligence: Literature Review

Scribano Parada MP, González Palau F, Valladares Rodríguez S, Rincon M, Rico Barroeta MJ, García Rodriguez M, Bueno Aguado Y, Herrero Blanco A, Díaz-López E, Bachiller Mayoral M, Losada Durán R.

JMIR Med Inform. 2025 Jan 28;13:e62914. doi: 10.2196/62914.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias